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Abstract: From 1940 to the mid-1960s, pulmonary metastasectomy
was performed infrequently and only in selected cases. Although the
number of nodules was not considered a contraindication to resec-
tion, patients with bilateral disease were believed to have a poor
prognosis and, thus, were not considered for operation. Later in
1970, metastasectomy was being undertaken with more liberal
indications with respect to numbers being removed. It must be borne
in mind that the number of metastases is a reflection of the degree of
dissemination of the cancer, although in current practice, the pres-
ence of multiple metastases is not a contraindication to metastasec-
tomy in either epithelial cancers or sarcomas.
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From 1940 to the mid-1960s, pulmonary metastasectomywas performed infrequently and only in selected cases.
For example, only 25 patients were surgically treated from
1942 to 1962 at the Memorial Sloan-Kettering Cancer Cen-
ter.1 Operation was not considered unless there was a long
interval between the resection of the primary tumor and
presentation with metastases or at least before resection of
those metastases was undertaken. Their rule then was that
there should be three or fewer lesions confined to one lung.
Similarly, from 1942 to 1961, the Mayo Clinic reported 225
metastasectomy operations on 205 patients with pulmonary
metastatic disease.2 Although the number of nodules was not
considered a contraindication to resection, patients with bi-
lateral disease were believed to have a poor prognosis and,
thus, were not considered for operation.
Later in 1970, reported experience from several insti-
tutions indicated that pulmonary metastasectomy was being
undertaken with more liberal indications with respect to
numbers being removed.2 However, in 1995, Halteren et al.,3
in a study of 38 patients who had been operated on in 12
hospitals, reported that the number of pulmonary metastases
was associated with outcome: all patients who had undergone
resection of four or more pulmonary metastases had tumor
progression within 16 months, whereas 50% of patients with
less than four metastases were still alive without evidence of
disease 5 years after metastasectomy. The authors concluded
that metastasectomy was associated with sufficiently good
survival and that patients should be offered this option.
However, it must be borne in mind that the number of
metastases is a reflection of the degree of dissemination of the
cancer and will, thus, be statistically associated with survival
with or without surgery.
Recent reports include some large numbers of metas-
tasectomies, in particular, a report on laser surgery, which
allows resection with minimal loss of parenchyma. In one
patient with disseminated breast cancer, 124 pulmonary me-
tastases were resected. In the report, there were 3267 nodules
removed from 328 patients, an average of 10 resections per
patient.4 We know from the European Society of Thoracic
Surgeons (ESTS) survey of practice that in current European
practice, 85% of respondents believe that multiple metastases
(1) is not a contraindication to metastasectomy, and none of
the respondents regarded the presence of multiple metastases
to be an absolute contraindication.5
In relation to colorectal cancer, there are many retro-
spective studies of surgical treatment for pulmonary metas-
tasis. In a systematic review of 51 reports of metastasectomy
for colorectal cancer,5a the number of metastases was pro-
vided in 38 publications. It can be seen that the proportion of
multiple metastasectomy operations has increased over time
from approximately 30 to 40%, but most operations are still
performed for a solitary metastases in these reported series
(Figure 1).
INFLUENCE OF THE NUMBER OF METASTASES
ON SURVIVAL
Reports of outcomes for patients who have undergone
pulmonary metastasectomy typically include different pri-
mary cancers. However, reports from the International Reg-
istry of Lung Metastasis6,7 divide the cases according to the
primary malignancies and show a general rule that survival
depends on the number of metastases. The understanding of
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this problem has improved with the appearance of articles
concerning the results of lung metastasectomy for homoge-
neous clinical series for various primary malignancies.8
There are many articles that include multivariable anal-
ysis, and we have found one article reported as a systematic
review.9 The analysis of series of patients treated in the past
25 years for pulmonary metastases shows an overall 5- and
10-year survival rates ranging from 35 to 45% and 20 to 30%,
respectively. Currently, many authors report higher survival
rates for patients with single lesions.9,10 Others,2,11,12 how-
ever, have not found correlation between either the number of
lung metastases or bilateral location and survival. However,
because more than half of all operated patients have only one
pulmonary metastasis removed, and most of the others have
small numbers, the full potential range of the variable entering
any data analysis is severely curtailed by case selection.
In relation to the surgical treatment of lung metastases
of soft tissue and bone sarcoma, in the review of the Euro-
pean Organization for Research Treatment of Cancer,13 the
majority of patients undergoing resection had only one lesion
(53%), although 15% of patients had more than four lesions
at the time of pulmonary metastasectomy. Number of metas-
tases is of greater prognostic value, and solitary lesion or low
number of nodules is identified as a good prognostic factor in
patients undergoing complete resection.14,15 In addition, a worse
survival was observed by Choong et al.16 in a series of 214
patients when size of lung metastases was 2 cm.
Billingsley et al.17 reported the patterns of disease and
survival after metastasectomy for patients with pulmonary
metastases from soft tissue sarcoma in a large group of 719
patients treated at Memorial Sloan-Kettering Cancer. Clinical
factors that influence postmetastasectomy survival were an-
alyzed, and the authors concluded that resection of metastatic
disease is the single most important factor that determines the
outcome in these patients. A disease-free interval of more
than 12 months before the development of metastases was
also a favorable prognostic factor. Patients treated with com-
plete resection had a median survival of 33 months and a
3-year actuarial survival rate of 46%. For patients treated
with nonoperative therapy, the median survival was 11
months. However, it should be remembered that there are
many unknown, unrecognized, or unrecorded factors that are
taken into consideration in the decision to operate. Having
had an operation is not a random event and may be a marker
for a cluster of factors recognized by experienced clinicians
as favoring a good outcome, which are not recorded in the
data set analyzed by the statistician.
In a report of Weiser et al.,18 outcomes are described by
factors that may be determined preoperatively, including
metastasis size, metastasis number, and primary tumor histo-
logic grade. Patients who cannot be completely re-resected or
those with numerous, large metastasis and high-grade pri-
mary tumor pathology have poor outcomes and should not be
offered surgical metastasectomy although they were consid-
ered for experimental treatments under investigation.
Bearing in mind these results, we could state that
complete resection of pulmonary metastatic disease and num-
ber of metastases are important prognostic factors for deter-
mining outcome in patients treated surgically of pulmonary
metastases from soft tissue sarcoma.
Cisplatin-based chemotherapy followed by surgical re-
section of residual benign disease represents the usual se-
quence of curative therapy for metastatic nonseminomatous
germ cell cancer of testicular origin.19 In contrast to the
outcomes in other malignancies, prognosis after lung metas-
tasectomy in the germ cell tumors seems to depend more on
the response to chemotherapy preoperative treatment than the
anatomic factors as the number or size of the metastases.
Nevertheless, recently, Kesler et al.20 in a large group of 134
patients found older age, pulmonary metastases (versus me-
diastinal metastases) and four or more (versus one) total
intrathoracic metastases as the most significant predictive
factors for lower long-term survival.
FIGURE 1. Percentage of patients
with multiple metastases according to
38 of 51 articles in which data were
presented (Fiorentino et al.).
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SUMMARY
We opened with a report from the Memorial Sloan-
Kettering Cancer Center 30 years ago.1 A recent article from
the same institution reporting on 378 patients with colorectal
cancer undergoing pulmonary metastasectomy in the past 20
years reminds us that with increasing numbers of metastases
resected, the length of survival shortens.21
1. The number of metastases resected is consistently
shown to be an adverse factor for survival after pulmo-
nary metastasectomy, where the number of patients and
the range of the metastasis count are large enough to
statistically explore the relationship.
2. It is clear that the number of metastases is a consistent
measure of the biologic aggressiveness of a cancer.
3. Pulmonary metastasectomy is unlikely to alter the
course of aggressive cancers, because they are likely to
be widely disseminated, other than in the lung, and that
will determine the outcome irrespective of surgery.
4. There is a technical limit to the number of metastases
that can realistically be removed, notwithstanding the
clinical view that there is no absolute limit.
CONCLUSIONS
Single pulmonary nodules deserve attention and prob-
ably merit tissue diagnosis in the majority of cases. As a
result, metastasectomy of single lung metastases is fully
justified as a part of this process, and some of these patients
may be cured of the only remaining disease. Those apart,
recommendations for surgery should be increasingly guarded
as the number of metastases increases. When there are more
than three or four metastases, the likelihood of prolonged
survival after metastasectomy diminishes.
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